262 related articles for article (PubMed ID: 35156574)
1. Targeting G-Quadruplex DNA for Cancer Chemotherapy.
Debbarma S; Acharya PC
Curr Drug Discov Technol; 2022; 19(3):e140222201110. PubMed ID: 35156574
[TBL] [Abstract][Full Text] [Related]
2. Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy.
Asamitsu S; Obata S; Yu Z; Bando T; Sugiyama H
Molecules; 2019 Jan; 24(3):. PubMed ID: 30682877
[TBL] [Abstract][Full Text] [Related]
3. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
[TBL] [Abstract][Full Text] [Related]
4. Structurally diverse G-quadruplexes as the noncanonical nucleic acid drug target for live cell imaging and antibacterial study.
Zheng BX; Yu J; Long W; Chan KH; Leung AS; Wong WL
Chem Commun (Camb); 2023 Feb; 59(11):1415-1433. PubMed ID: 36636928
[TBL] [Abstract][Full Text] [Related]
5. Metal-Organic Compounds as Anticancer Agents: Versatile Building Blocks for Selective Action on G-quadruplexes.
Toro PM; Saldias M; Valenzuela-Barra G
Curr Med Chem; 2023; 30(5):573-600. PubMed ID: 35670351
[TBL] [Abstract][Full Text] [Related]
6. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
7. Rational design of small-molecules to recognize G-quadruplexes of c-MYC promoter and telomere and the evaluation of their in vivo antitumor activity against breast cancer.
Long W; Zheng BX; Li Y; Huang XH; Lin DM; Chen CC; Hou JQ; Ou TM; Wong WL; Zhang K; Lu YJ
Nucleic Acids Res; 2022 Feb; 50(4):1829-1848. PubMed ID: 35166828
[TBL] [Abstract][Full Text] [Related]
8. G-quadruplex in cancer biology and drug discovery.
Nakanishi C; Seimiya H
Biochem Biophys Res Commun; 2020 Oct; 531(1):45-50. PubMed ID: 32312519
[TBL] [Abstract][Full Text] [Related]
9. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting.
Romano F; Di Porzio A; Iaccarino N; Riccardi G; Di Lorenzo R; Laneri S; Pagano B; Amato J; Randazzo A
Expert Opin Ther Pat; 2023 Nov; 33(11):745-773. PubMed ID: 37855085
[TBL] [Abstract][Full Text] [Related]
10. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex.
Hu MH; Lin JH; Huang Q
Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695
[TBL] [Abstract][Full Text] [Related]
12. Insight Derived from Molecular Dynamics Simulation into the Selectivity Mechanism Targeting
Wang Z; Li G; Tian Z; Lou X; Huang Y; Wang L; Li J; Hou T; Liu JP
J Phys Chem B; 2020 Nov; 124(44):9773-9784. PubMed ID: 33089692
[TBL] [Abstract][Full Text] [Related]
13. Non-duplex G-Quadruplex DNA Structure: A Developing Story from Predicted Sequences to DNA Structure-Dependent Epigenetics and Beyond.
Sengupta A; Roy SS; Chowdhury S
Acc Chem Res; 2021 Jan; 54(1):46-56. PubMed ID: 33347280
[TBL] [Abstract][Full Text] [Related]
14. G-quadruplex-R-loop interactions and the mechanism of anticancer G-quadruplex binders.
Miglietta G; Russo M; Capranico G
Nucleic Acids Res; 2020 Dec; 48(21):11942-11957. PubMed ID: 33137181
[TBL] [Abstract][Full Text] [Related]
15. Template-Assembled Synthetic G-Quartets (TASQs): multiTASQing Molecular Tools for Investigating DNA and RNA G-Quadruplex Biology.
Monchaud D
Acc Chem Res; 2023 Feb; 56(3):350-362. PubMed ID: 36662540
[TBL] [Abstract][Full Text] [Related]
16. Quadruplex-coupled kinetics distinguishes ligand binding between G4 DNA motifs.
Halder K; Chowdhury S
Biochemistry; 2007 Dec; 46(51):14762-70. PubMed ID: 18052204
[TBL] [Abstract][Full Text] [Related]
17. Recent Update on Targeting
Chaudhuri R; Bhattacharya S; Dash J; Bhattacharya S
J Med Chem; 2021 Jan; 64(1):42-70. PubMed ID: 33355454
[TBL] [Abstract][Full Text] [Related]
18. EMICORON: A multi-targeting G4 ligand with a promising preclinical profile.
Porru M; Zizza P; Franceschin M; Leonetti C; Biroccio A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1362-1370. PubMed ID: 27838395
[TBL] [Abstract][Full Text] [Related]
19. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
20. DNA G-quadruplex-stabilizing metal complexes as anticancer drugs.
Zegers J; Peters M; Albada B
J Biol Inorg Chem; 2023 Mar; 28(2):117-138. PubMed ID: 36456886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
